Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

5 terminated out of 45 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

16%

7 trials in Phase 3/4

Results Transparency

30%

6 of 20 completed with results

Key Signals

6 with results80% success

Data Visualizations

Phase Distribution

22Total
Not Applicable (12)
P 1 (1)
P 2 (2)
P 3 (3)
P 4 (4)

Trial Status

Completed20
Recruiting9
Unknown6
Terminated5
Enrolling By Invitation2
Active Not Recruiting2

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT04998812Phase 4Completed

A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy

NCT05057676Not ApplicableRecruiting

Autoimmune Intervention Mastery Course Study

NCT04798651Not ApplicableRecruiting

Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis

NCT04466150Phase 4Active Not Recruiting

Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset

NCT04998851Phase 4Completed

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab

NCT07280871Not Yet Recruiting

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care

NCT04009005Not ApplicableActive Not RecruitingPrimary

Clinically Isolated Syndrome and Relapsing-Remitting Multiple Sclerosis

NCT06280755Recruiting

Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.

NCT07032246Not ApplicableEnrolling By Invitation

Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study

NCT03541226CompletedPrimary

Clinical Monitoring, MRI and Neuro-Ophthalmology of a Cohort of Patients With a Clinically Isolated Syndrome (CIS)

NCT06274671RecruitingPrimary

Glymphatic MRI in Clinically Isolated Syndrome

NCT06455332Not ApplicableRecruitingPrimary

Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

NCT05706220Enrolling By Invitation

Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

NCT06940323Recruiting

Pregnancy Registry, Infants, Serum/Milk Analysis (PRISMA)

NCT06541626Recruiting

Sun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases

NCT06526000Completed

Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies

NCT06395909Completed

A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis

NCT02043964Not ApplicableCompletedPrimary

Tear Analysis by Isoelectric Focusing in Clinically Isolated Syndrome as Multiple Sclerosis Criterion

NCT05204459Recruiting

MS-ResearchBiomarkerS

NCT03872583Not ApplicableCompleted

Understanding Magnetic Resonance Imaging in Multiple Sclerosis

Scroll to load more

Research Network

Activity Timeline